Serum Regulates the Expression of Complement Receptor 2 on Human B Cell Lines

References

• Fearon D. T., Carter R. H. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu. Rev. Immunol. 1995; 13: 127
   PubMed Web of Science ®Google Scholar
• Carroll M. C., Fischer M. B. Complement and the immune response. Curr. Opin. Immunol. 1997; 9: 64
   PubMed Web of Science ®Google Scholar
• Tolnay M., Tsokos G. C. Complement receptor 2 in the regulation of the immune response. Clin. Immunol. Immunopathol. 1998; 88: 123
   PubMedGoogle Scholar
• O'Rourke L., Tooze R., Fearon D. T. Co-receptors of B lymphocytes. Curr. Opin. Immunol. 1997; 9: 324
   PubMed Web of Science ®Google Scholar
• Tedder T. F., Zhou L. J., Engel P. The CD19/CD21 signal transduction complex of B lymphocytes. Immunol. Today 1994; 15: 437
   PubMedGoogle Scholar
• Carter R. H., Fearon D. T. CD 19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 1992; 256: 105
   PubMed Web of Science ®Google Scholar
• Jackson C. G., Ochs H. D., Wedgewood R. J. Immune response of a patient with deficiency of the fourth component of complement and systemic lupus erythematosus. N. Engl. J. Med. 1979; 300: 1124
   PubMedGoogle Scholar
• Bottger E. C., Hoffmann T., Hadding U., Bitter-Sauermann D. Influence of genetically inherited complement deficiencies on humoral immune response in guinea pigs. J. Immunol. 1985; 135: 4100
   PubMedGoogle Scholar
• Klaus G. G., Humphrey J. H. The generation of memory B cells. I. The role of C3 in the generation of B memory cells. Immunology 1977; 33: 31
   PubMed Web of Science ®Google Scholar
• Molina H., Holers V. M., Li B., Fung Y., Mariathasan S., Goellner J., Strauss-Schoenberger J., Karr R. W., Chaplin D. D. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. U.S.A. 1996; 93: 3357
   PubMed Web of Science ®Google Scholar
• Ahearn J. M., Fischer M. B., Croix D., Goerg S., Ma M., Xia J., Zhou X., Howard R. G., Rothstein T. L., Carroll M. C. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 1996; 4: 251
   PubMed Web of Science ®Google Scholar
• Boyd A. W., Anderson K. C., Freedman A. S., Fisher D. C., Slaughenhoupt B., Schlossman S. F., Nadler L. M. Studies of in vitro activation and differentiation of human B lymphocytes. I. Phenotypic and functional characterization of the B cell population responding to anti-Ig antibody. J. Immunol. 1985; 134: 1516
   PubMed Web of Science ®Google Scholar
• Timens W., Boes A., Poppema S. Human marginal zone B cells are not an activated B cell subset: strong expression of CD21 as a putative mediator for rapid B cell activation. Eur. J Immunol. 1989; 19: 2163
   PubMedGoogle Scholar
• Takahashi K., Kozono Y., Waldschmidt T. J., Berthiaume D., Quigg R. J., Baron A., Holers V. M. Mouse complement receptor type 1 (CR1; CD35) and type 2 (CR2; CD21) expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice. J. Immunol. 1997; 159: 1557
   PubMed Web of Science ®Google Scholar
• Rayhel E. J., Dehoff M. H., Holers V. M. Characterization of the human complement receptor 2 (CR2, CD21) promoter reveals sequences shared with regulatory regions of other developmentally restricted B cell proteins. J. Immunol. 1991; 146: 2021
   PubMed Web of Science ®Google Scholar
• Yang L. M., Behrens M., Weis J. J. Identification of 5′-regions affecting the expression of the human CR2 gene. J. Immunol. 1991; 147: 2404
   PubMedGoogle Scholar
• Hu H., Martin B. K., Weis J. J., Weis J. H. Expression of the murine CD21 gene is regulated by promoter and intronic sequences. J. Immunol. 1997; 158: 4758
   PubMedGoogle Scholar
• Makar K. W., Pham C. T., Dehoff M. H., O'Connor S. M., Jacobi S. M., Holers V. M. An intronic silencer regulates B lymphocyte cell-and stage-specific expression of the human complement receptor type 2 (CR2, CD21) gene. J. Immunol. 1998; 160: 1268
   PubMedGoogle Scholar
• Tolnay M., Lambris J. D., Tsokos G. C. Transcriptional regulation of the complement receptor 2 gene: role of a heterogeneous nucler ribonucleoprotein. J. Immunol. 1997; 159: 5492
   PubMedGoogle Scholar
• Treisman R. Ternary complex factors: growth factor regulated transcriptional activators. Curr. Opin. Genet. Dev. 1994; 4: 96
   PubMedGoogle Scholar
• Noguchi P. D. Use of flow cytometry for DNA analysis. Current Protocols in Immunology, J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, W. Strober. Current Protocols. 1994; 5.7.1
   Google Scholar
• Erdei A., Melchers F., Schulz T., Dierich M. The action of human C3 in soluble or cross-linked form with resting and activated murine B lymphocytes. Eur J Immunol. 1985; 15: 184
   PubMedGoogle Scholar
• Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987; 162: 156
   PubMed Web of Science ®Google Scholar
• Sambrook J., Fritsch E. F., Maniatis T. Northern hybridization. Molecular Cloning. 2nd ed. Cold Spring Harbor Laboratory Press. 1989; 7.39
   Google Scholar
• Matsumoto A. K., Kopicky-Burd J., Carter R. H., Tuveson D. A., Tedder T. F., Fearon D. T. Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19. J. Exp. Med. 1991; 173: 55
   PubMed Web of Science ®Google Scholar
• Bradbury L. E., Kansas G. S., Levy S., Evans R. L., Tedder T. F. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J. Immunol. 1992; 149: 2841
   PubMed Web of Science ®Google Scholar
• Pillemer S. R., Tsokos G. C., Barbieri S. A., Balow J. E., Golding B. The CR2 receptor (CD21) shows increased expression in the more differentiated cells of an antigen-specific B cell line. Cell. Immunol. 1990; 125: 386
   PubMedGoogle Scholar
• Pernegger G., Schulz T. F., Hosp M., Myones B. L., Petzer A. L., Eigentler A., Bock G., Wick G., Dierich M. P. Cell cycle control of a Burkitt lymphoma cell line: responsiveness to growth signals engaging the C3D/EBV receptor. Immunology 1988; 65: 237
   PubMedGoogle Scholar
• Bennett M. R., Littlewood T. D., Hancock D. C., Evan G. I., Newby A. C. Down-regulation of the c-myc proto-oncogene in inhibition of vascular smooth-muscle cell proliferation: a signal for growth arrest. Biochem. J. 1994; 302: 701
   PubMed Web of Science ®Google Scholar
• Cocks B. G., Vairo G., Bodrug S. E., Hamilton J. A. Suppression of growth factor-induced CYCL1 cyclin gene expression by antiproliferative agents. J. Biol. Chem. 1992; 267: 12307
   PubMed Web of Science ®Google Scholar
• Vairo G., Argyriou S., Knight K. R., Hamilton J. A. Inhibition of coloni-stimulating factor-stimulated macrophage proliferation by tumor necrosis factor-alpha, IFN-gamma, and lipopolysaccharide is not due to a general loss of responsiveness to growth factor. J. Immunol. 1991; 146: 3469
   PubMed Web of Science ®Google Scholar
• Saunders N. A., Smith R. J., Jetten A. M. Differential responsiveness of human bronchial epithelial cells, lung carcinoma cells, and bronchial fibroblasts to interferon-gamma in vitro. Am. J. Respir. Cell. Mol. Biol. 1994; 11: 147
   PubMedGoogle Scholar
• Kuraya M., Yefenof E., Klein G., Klein E. Expression of the complement regulatory proteins CD21, CD55 and CD59 on Burkitt lymphoma lines: their role in sensitivity to human serum-mediated lysis. Eur. J. Immunol. 1992; 22: 1871
   PubMedGoogle Scholar
• Carel J. C., Frazier B., Ley T. J., Holers V. M. Analysis of epitope expression and the functional repertoire of recombinant complement receptor 2 (CR2/CD21) in mouse and human cells. J. Immunol. 1989; 143: 923
   PubMedGoogle Scholar
• Servis C., Lambris J. D. C3 synthetic peptides support growth of human CR2-positive lymphoblastoid B cells. J. Immunol. 1989; 142: 2207
   PubMedGoogle Scholar
• Hatzfeld A., Fischer E., Levesque J. P., Perrin R., Hatzfeld J., Kazatchkine M. D. Binding of C3 and C3dg to the CR2 complement receptor induces growth of an Epstein-Barr virus-positive human B cell line. J. Immunol. 1988; 140: 170
   PubMedGoogle Scholar
• Treisman R. Transient accumulation of c-fos RNA following serum stimulation requires a conserved 5′element and c-fos 3′sequences. Cell 1985; 42: 889
   PubMed Web of Science ®Google Scholar
• Treisman R. Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors. Cell 1986; 46: 567
   PubMed Web of Science ®Google Scholar